Benzinga | Mar 3, 2021 08:09AM EST

Ekso Bionics Teams Up with Performance Contracting, Inc. for Innovative Testing Approach of EVO Technology

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today announced that Performance Contracting, Inc. ("PCI"), a leading U.S. specialty contractor, is the latest company in the construction vertical to implement field testing of EVO(tm) exoskeleton vests. Over the course of a year, PCI employees in six Bay Area counties have committed to testing EVO(tm) exoskeleton vests for the Company's continued product development and innovation.

"We are excited that PCI's workforce will benefit from our novel EVO technology," commented Michael Pratt, Vice President of Ekso Bionics. "Companies within the construction vertical are starting to recognize that EVO provides meaningful support for workers when performing routine and labor-intensive tasks. We look forward to supporting our growing user base, including PCI, with our unique solution and driving increased adoption with our flexible subscription-based offering."

EVO is the world's most durable, naturally-tracking, and assistive exoskeleton vest. The exoskeleton offers unique benefits in the construction industry that aids workers when performing strenuous tasks in order to reduce fatigue and worker-related injuries while increasing productivity.

"Putting our people first has always been a key differentiator at PCI," said David Link, Regional Manager, Bay Area of PCI. "With our team of over 6,300 skilled craft workers across the United States, it is imperative for us to invest in both their well-being and productivity to remain an industry leader. Ekso's EVO aligns with our most important core value of safety and supports our performance-driven culture. We are eager to explore this technology in the field with the goal of helping our employees achieve their fullest potential."